VisMederi Pharma is part of the larger VisMederi Group (www.vismederi.com), a group with relevant experience in evaluating the immunogenicity of vaccines, with particular attention to influenza and SARS-CoV-2 serology.
VisMederi Pharma is a new and original reality which, however, arises from the extensive expertise of its founders. It aims at contributing to the improvement of people’s health and well-being through the development, production and distribution of therapeutic products, diagnostics, supplements and, in the future, vaccines, by adopting an innovative and original business model. VisMederi Pharma’s mission is to protect people from serious infectious diseases, including those caused by emerging pathogens, in order to foster rapid and timely diagnosis, as well as to offer support in the course of medical therapies. VisMederi Pharma operates in the Pharmaceutical Sciences sector, following a consolidated centuries-old tradition on the Sienese territory.
